Related Experiment Video
Updated: Jan 16, 2026
Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Eldecalcitol ameliorates type 2 diabetic osteoporosis by attenuating endothelial ferroptosis via the
Yaling Dai1, Yujun Jiang1, Xiaolin Li1
1Department of Bone Metabolism, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration & Shandong Provincial Clinical Research Center for Oral Diseases, Jinan, China; Center of Osteoporosis and Bone Mineral Research, Shandong University, Jinan, China.
Abstract:
Accelerated bone degradation and increased risk of fractures, which lead to osteoporosis in patients, are common complications of type 2 diabetes (T2DM), severely impairing the quality of life of patients worldwide. Eldecalcitol (1α,25-dihydroxy-2β-(3-hydroxypropoxy) vitamin D3, or ED71) is a novel active vitamin D analog that has been used in the treatment of postmenopausal osteoporosis. However, its specific regulatory mechanism on endothelial cell function in the context of ferroptosis, as well as its impact on osteogenesis-angiogenesis coupling in type 2 diabetic osteoporosis (T2DOP) remains unclear. The results showed that ED71 plays a role in the impaired osteogenesis and endothelial ferroptosis induced by high glucose and high fat (HGHF), as evidenced by the changes in vascular proliferation, generation and migration, as well as the improvement of osteogenesis of bone marrow mesenchymal stem cells (BMSCs) and the decrease of endothelial ferrous ion (Fe2+) level, lipid peroxidation and mitochondrial membrane potential. In addition, ED71 treatment significantly alleviated the impaired osteogenesis and angiogenesis and decreased ferroptosis markers in mouse T2DOP. When exploring the potential mechanism of action, we observed that ED71 suppressed ferroptosis by rescuing store-operated calcium entry (SOCE) mediated calcium signaling and subsequently normalizing aberrant O-GlcNAcylation, and the introduction of the SOCE inhibitor 2-aminoethyl diphenylborinate (2APB) and the OGlcNAcylation inhibitor OSMI-1 counteracted the beneficial effects of ED71 in HGHF-treated endothelial cells. In conclusion, these data suggest that ferroptosis of endothelial cells is associated with T2DOP, and ED71 can regulate ferroptosis of endothelial cells through the SOCE/OGlcNActlation aixs, thereby targeting and modulating bone homeostasis.
Related Concept Videos
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Osteoclasts in Bone Remodeling
00:51Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
01:40Bone Remodeling
01:21Skeleton and Calcium Homeostasis
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...